Connor, Clark & Lunn Investment Management (CC&L)’s Twist Bioscience TWST Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36,322	Closed	-$3.88M	–	1211
2021 Q3	$3.88M	Sell	36,322 -13,486	-27%	-$1.54M	0.02%	390
2021 Q2	$6.64M	Buy	49,808 +44,185	+786%	+$5.14M	0.03%	303
2021 Q1	$696K	Buy	5,623 +4,132	+277%	+$627K	﹤0.01%	751
2020 Q4	$211K	Sell	1,491 -2,238	-60%	-$248K	﹤0.01%	820
2020 Q3	$283K	Buy	+3,729	New	+$232K	﹤0.01%	800

Other funds holding TWST

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TWST Position: Q4 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Twist Bioscience (TWST) in Q4 2021, closing a stake of 36,322 shares — an estimated $3.88M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TWST in Q3 2020 and held it in 5 quarters. The position peaked at $6.64M in Q2 2021. 237 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Twist Bioscience position as of Q4 2021 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 36,322 Twist Bioscience shares in Q4 2021, an estimated $3.88M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Twist Bioscience in Q3 2020 and held it in 5 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Twist Bioscience position peaked at $6.64M in Q2 2021.
237 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2021, filed 10 Feb 2022.